Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging
Article in Frontiers in Medicine (January 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Frontiers in Medicine (January 2024)
Article in International Journal of Molecular Sciences (January 2024)
Article in Molecular Therapy — Methods & Clinical Development (November 2023)